XM does not provide services to residents of the United States of America.
S
S

Sonova


News

Sonova drops as Barclays downgrades, saying recent launches priced in

BUZZ-Sonova drops as Barclays downgrades, saying recent launches priced in ** Barclays cuts Sonova SOON.S to "equal-weight" from "overweight", saying the Swiss hearing aid group's most recent launches have already been priced in ** Shares in Sonova are down 1.6% ** Barclays says the company's FY guidance is "achievable", but points to limited catal
S
A

BMW, Kingfisher, Spectris

EUROPE RESEARCH ROUNDUP-BMW, Kingfisher, Spectris Sept 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including BMW, Kingfisher and Spectris, on Wednesday. HIGHLIGHTS * BMW BMWG.DE : Citigroup raises to neutral from sell * Entain ENT.L : Berenberg raises target price to 1,030p from 1,020p * Kingfisher KGF.L : Citigroup raises target price to 301p from 292p * Spectris SXS.L : HSBC cuts to hold from buy * Whitbread WTB.L : Goldman Sachs cu
A
A
A
B
B
B
C
C
C
D
D
E
E
G
H
I
K
K
S
S
S
W
A
A
A
E
M

Hearing aid makers slip after Apple rolls out hearing aid features, analysts shrug off threat

Hearing aid makers slip after Apple rolls out hearing aid features, analysts shrug off threat Sept 10 (Reuters) - Shares in European hearing aid makers slipped in early trading on Tuesday after Apple AAPL.O rolled out hearing aid features. Apple said its AirPods Pro 2 could now be "transformed" into a personalized hearing aid via an upcoming software update that would boost specific sounds in real time, including parts of speech or elements within a user's environment.
A
S
A

Banks, energy stocks weigh on European bourses; BMW tumbles

UPDATE 2-Banks, energy stocks weigh on European bourses; BMW tumbles STOXX 600 down 0.5% BMW slumps after cutting profit margin outlook Germany's inflation slowed to 0.2% in August AstraZeneca falls, lung cancer drug trial fails to improve survival Updated at 1615 GMT By Pranav Kashyap and Lisa Pauline Mattackal Sept 10 (Reuters) - European equity markets largely lost ground on Tuesday, weighed by bank and energy stocks as investors tread cautiously ahead of key U.S.
A
A
B
C
C
S
S
A
E
F
U
G

European hearing aid makers slide after Apple rolls out hearing aid features

BUZZ-European hearing aid makers slide after Apple rolls out hearing aid features ** Shares in hearing aid makers slip on Tuesday after Apple AAPL.O rolled out hearing aid features that it has submitted for U.S. regulatory review ** Apple said that its AirPods Pro 2 can be "transformed" into a personalized hearing aid via an upcoming software updat
A
S
A

UBS starts Demant with 'buy', cuts Coloplast to 'sell'

BUZZ-UBS starts Demant with 'buy', cuts Coloplast to 'sell' ** UBS initiates coverage of medical devices maker Demant DEMANT.CO with "buy" rating, and downgrades its Danish peer Coloplast COLOb.CO to "sell" from "neutral" ** It sees Demant to deliver a 13% EPS compound annual growth rate (CAGR) for 2024-2028, ahead of both Swiss rival Sonova SOON.S
S

Accelleron, BHP, Kingfisher

EUROPE RESEARCH ROUNDUP-Accelleron, BHP, Kingfisher Aug 28 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Accelleron, BHP and Kingfisher, on Wednesday. HIGHLIGHTS * Accelleron ACLN.S : Deutsche Bank raises target price to CHF 42 from CHF 34 * BHP Group BHPB.L : JP Morgan cuts target price to 2,580p from 2,650p * Kingfisher KGF.L : Citigroup cuts to neutral from buy * Vonovia SE VNAn.DE : Citigroup raises target price to EUR 52.80 f
A
A
A
B
B
B
C
C
D
E
I
K
N
P
S
S
S
S
T
V
H
B
D

Jefferies says Demant nears valuation trough, ups to 'hold'

BUZZ-Jefferies says Demant nears valuation trough, ups to 'hold' ** Jefferies upgrades Danish hearing aid maker Demant DEMANT.CO to "hold" from "underperform" on low relative valuation, but notes an absence of catalysts for the stock ** It says Demant is nearing a trough in valuation, after Swiss rival Sonova SOON.S outperformed it over the past three months ** Demant's profit warning in July reflects the impact of its brand strategy in the U.S.
S

Top of the Street: UCB, Moncler, Sonova, Moncler, Voestalpine

BUZZ-Top of the Street: UCB, Moncler, Sonova, Moncler, Voestalpine A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** JP Morgan raises UCB UCB.BR to "overweight" from "neutral" as it sees the Belgian biotech firm's "superior growth profile" as "significantly" undervalued by the market; cites expected acceleration in Bimzelx growth ** Morgan Stanley downgrades Sonova SOON.S to "underweight" from "equal-weight", flagging the hearing aid maker's EV/EBITA valua
M
S
U
V
V

Morgan Stanley upgrades hearing aid maker Demant, cuts peer Sonova

BUZZ-Morgan Stanley upgrades hearing aid maker Demant, cuts peer Sonova ** Morgan Stanley upgrades hearing aid maker Demant DEMANT.CO to "overweight" from "underweight", while downgrading its peer Sonova SOON.S to "underweight" from "equal-weight" ** Sees an attractive entry point for Demant, citing de-risked estimates after the profit warning and
S

Admiral, UCB SA, Victrex

EUROPE RESEARCH ROUNDUP-Admiral, UCB SA, Victrex Aug 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Admiral, UCB SA and Victrex, on Wednesday. HIGHLIGHTS * Admiral ADML.L : RBC raises target price to 3,550p from 3,400p * Demant A/S DEMANT.CO : Morgan Stanley raises to overweight from underweight * UCB SA UCB.BR : JP Morgan raises to overweight from neutral * Victrex Plc VCTX.L : Jefferies raises to hold from underperform * Watki
A
A
C
H
I
M
N
R
S
S
U
V
V
A

Sonova launches hearing aid with real-time AI, first in market

UPDATE 1-Sonova launches hearing aid with real-time AI, first in market Adds share move in paragraph 1, analysts comments in paragraphs 4 and 6 By Amir Orusov and Anastasiia Kozlova Aug 6 (Reuters) - Switzerland's Sonova SOON.S on Tuesday introduced a hearing aid that utilises real-time artificial intelligence to improve speech clarity from background noise, the first such product in the global market, sending its shares 5% higher.
S
A

Europe's STOXX 600 edges up in global recovery, earnings relief

UPDATE 2-Europe's STOXX 600 edges up in global recovery, earnings relief For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window German industrial orders swell in ray of hope for weak economy Novo Nordisk logs biggest one-day gain in five months Bayer shares drop after earnings hit by tough farm market Monte dei Paschi di Siena up after raising profit outlook STOXX 600 up 0.3% Updated at 1600 GMT By Pranav Kashyap and Ankika Biswas Aug 6 (Reuter
A
B
R
S
Z
A
M
J
F
S
G

Sonova launches hearing aid with real-time AI, first in market

Sonova launches hearing aid with real-time AI, first in market By Amir Orusov and Anastasiia Kozlova Aug 6 (Reuters) - Switzerland's Sonova SOON.S on Tuesday introduced a hearing aid that utilises real-time artificial intelligence to improve speech clarity from background noise, the first such product in the global market. Along with the hearing aid, named Sphere Infinio, Sonova is launching a new Infinio platform.
S
A

Sonova: Announces Two New Hearing Aid Platforms, One With Real-Time AI

BRIEF-Sonova: Announces Two New Hearing Aid Platforms, One With Real-Time AI Aug 6 (Reuters) - SONOVA HOLDING AG SOON.S : ANNOUNCES TWO NEW HEARING AID PLATFORMS, INCLUDING FIRST HEARING AID WITH REAL-TIME AI CUSTOMERS CAN EXPECT NEW HEARING AIDS TO BE AVAILABLE FROM AUGUST THIS YEAR Further company coverage: SOON.S (Gdansk Newsroom)
S

Top of the Street: Nestle, Anglo American, Bureau Veritas

BUZZ-Top of the Street: Nestle, Anglo American, Bureau Veritas A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank downgrades Nestle NESN.S to "hold" from "buy", saying the world's biggest packaged food company went "a cut too far" as it trimmed its sales growth outlook on Thursday ** UBS raises British miner Anglo American AAL.L to "buy" from "neutral" as it sees better risk/reward ratio after the stock fell enough following BHP's BHP.AX offer
B
B
N
S
A
M

Demant drops after profit warning

BUZZ-Demant drops after profit warning ** Shares in Demant DEMANT.CO fall around 10% to November lows after the Danish hearing aid maker cut its full-year outlook , citing a "significant" loss of market share for the managed care brand ** Demant now forecasts its organic revenue in 2024 to grow 2-4% against 4-8% seen earlier, expecting continuous low growth in the Hearing Aids unit ** It cuts adjusted EBIT guidance to 4.30-4.60 billion Danish crowns ($629-$672 million) from 4.60-5.00 billion cro
S
A



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.